Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0VP5X
|
||||
Former ID |
DIB013871
|
||||
Drug Name |
Research programme: peroxisome proliferator-activated receptor gamma agonist, Omeros
|
||||
Synonyms |
PPAR gamma agonists (addiction); PPAR gamma agonists (addiction), Omeros; Peroxisome proliferated-activated receptor gamma agonists (addiction), Omeros
|
||||
Indication | Drug abuse [ICD9: 303-304; ICD10:F10-F19] | Phase 2 | [549866] | ||
Company |
Omeros Corp
|
||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | Agonist | [549867] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.